Commercial International Bank -Egypt S.A.E (CBKD)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 2.210 |
|---|---|
| 52-week range | 2.065 – 2.975 |
| Return, 1 month / 3 months | −7.9% / −16.8% |
| Return, 1 year / 3 years | +18.2% / +137.9% |
| Trend | Below its 200-day average |
| RSI (14) | 34 |
| Volatility (1 year) | 35.3% |
| Worst drawdown (1 year) | -28.4% |
| Average daily value traded | 1.79M USD |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Commercial International Bank is an Egyptian bank based in Cairo that serves individuals, businesses and institutions. It offers retail banking such as current and savings accounts, personal loans, mortgages and cards, alongside corporate and investment banking, trade finance, treasury services and wealth management. Its customers include large companies, small and medium-sized enterprises and individual depositors, mainly in Egypt, with some international operations and a presence in the United Kingdom through a subsidiary.
The shares are listed on the London Exchange in UK under the code CBKD, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Commercial International Bank -Egypt S.A.E (CBKD) trades on the London Exchange in UK. It last closed at USD 2.210 on 23 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 2,504 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 18.2% and over the last three months it fell 16.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.3% | ||
| From 52-week high | -24.8% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -16.8% | ||
| 6-month return | -12.6% | ||
| 12-month return, skipping the last month | 28.4% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.4% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.79M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 21 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.0% |
|---|---|
| 1 month | −7.9% |
| 3 months | −16.8% |
| 6 months | −12.6% |
| 1 year | +18.2% |
| 3 years | +137.9% |
| 5 years | +42.3% |
Signals
| 50-day / 200-day average | 2.462 / 2.492 |
|---|---|
| Golden / death cross (60 days) | Death, 3 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.050 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Apr 2026 | EGP 0.0970 |
| 4 Apr 2025 | EGP 0.0461 |
| 18 Apr 2024 | EGP 0.0109 |
| 31 Mar 2023 | EGP 0.0165 |
| 1 Apr 2022 | EGP 0.0697 |
| 3 Apr 2020 | EGP 0.0712 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.